Myocardial HLA-G Reliably Indicates a Low Risk of Acute Cellular Rejection in Heart Transplant Recipients

Journal of Heart and Lung Transplantation

Volumn 27, Issue 5, 2008, Pages 522-527

  Sheshgiri, Rohit ^a   Rouas Freiss, Nathalie ^b   Rao, Vivek ^a   Butany, Jagdish ^a   Ramzy, Danny ^a   Krawice Radanne, Irene ^b   Ross, Heather J ^a   Carosella, Edgardo D ^b   Delgado, Diego H ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HLA G ANTIGEN;

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; STAINING; STATISTICAL SIGNIFICANCE; SURGICAL RISK;

ADOLESCENT; ADULT; AGED; FEMALE; GENE EXPRESSION; GRAFT REJECTION; HEART TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; RISK FACTORS;

EID: 42649105804     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.02.004     Document Type: Article

References (30)

1. Kovats S., Main E.K., Librach C., et al. A class I antigen, HLA-G, expressed in human trophoblasts. Science 248 (1990) 220-223
2. McMaster M.T., Librach C.L., Zhou Y., et al. Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. J Immunol 154 (1995) 3771-3778
3. Rouas-Freiss N., Goncalves R.M., Menier C., Dausset J., and Carosella E.D. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci USA 94 (1997) 11520-11525
4. Marchal-Bras-Goncalves R., Rouas-Freiss N., Connan F., et al. A soluble HLA-G protein that inhibits natural killer cell-mediated cytotoxicity. Transplant Proc 33 (2001) 2355-2359
5. LeMaoult J., Krawice-Radanne I., Dausset J., and Carosella E.D. HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells. Proc Natl Acad Sci USA 101 (2004) 7064-7069
6. Le Rond S., Azema C., Krawice-Radanne I., et al. Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/regulatory T cells. J Immunol 176 (2006) 3266-3276
7. Bainbridge D., Ellis S.A., and Sargent I.L. HLA-G suppresses proliferation of CD4+ T-lymphocytes. J Reprod Immunol 48 (2000) 17-26
8. Lila N., Rouas-Freiss N., Dausset J., Carpentier A., and Carosella E.D. Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism. Proc Natl Acad Sci USA 98 (2001) 12150-12155
9. Fournel S., Aguerre-Girr M., Huc X., et al. Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol 164 (2000) 6100-6104
10. Ishitani A., and Geraghty D.E. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci USA 89 (1992) 3947-3951
11. Paul P., Cabestre F.A., Ibrahim E.C., et al. Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Hum Immunol 61 (2000) 1138-1149
12. Carosella E.D., Moreau P., Le Maoult J., et al. HLA-G molecules: from maternal-fetal tolerance to tissue acceptance. Adv Immunol 81 (2003) 199-252
13. Rouas-Freiss N., Moreau P., Ferrone S., and Carosella E.D. HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?. Cancer Res 65 (2005) 10139-10144
14. Rouas-Freiss N., LeMaoult J., Moreau P., Dausset J., and Carosella E.D. HLA-G in transplantation: a relevant molecule for inhibition of graft rejection?. Am J Transplant 3 (2003) 11-16
15. Creput C., Durrbach A., Menier C., et al. Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation. J Hepatol 39 (2003) 587-594
16. Lila N., Carpentier A., Amrein C., et al. Implication of HLA-G molecule in heart-graft acceptance. Lancet 355 (2000) 2138
17. Lila N., Amrein C., Guillemain R., et al. Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation 105 (2002) 1949-1954
18. Stewart S., Winters G.L., Fishbein M.C., et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 24 (2005) 1710-1720
19. Stam N.J., Spits H., and Ploegh H.L. Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J Immunol 137 (1986) 2299-2306
20. Paul P., Rouas-Freiss N., Moreau P., et al. HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression. Hum Immunol 61 (2000) 1177-1195
21. Menier C., Saez B., Horejsi V., et al. Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA class I molecules. Hum Immunol 64 (2003) 315-326
22. Hviid T.V., Hylenius S., Rørbye C., and Nielsen L.G. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 55 (2003) 63-79
23. Rebmann V., van der Ven K., Passler M., et al. Association of soluble HLA-G plasma levels with HLA-G alleles. Tissue Antigens 57 (2001) 15-21
24. Luque J., Torres M.I., Aumente M.D., et al. sHLA-G levels in the monitoring of immunosuppressive therapy and rejection following heart transplantation. Transplant Immunol 17 (2006) 70-73
25. Luque J., Torres M.I., Aumente M.D., et al. Soluble HLA-G in heart transplantation: their relationship to rejection episodes and immunosuppressive therapy. Hum Immunol 67 (2006) 257-263
26. Lila N., Amrein C., Guillemain R., et al. Soluble human leukocyte antigen-G: a new strategy for monitoring acute and chronic rejections after heart transplantation. J Heart Lung Transplant 26 (2007) 421-422
27. Bastürk B., Karakayali F., Emiroglu R., et al. Human leukocyte antigen-G, a new parameter in the follow-up of liver transplantation. Transplant Proc 38 (2006) 571-574
28. Creput C., Le Friec G., Bahri R., et al. Detection of HLA-G in serum and graft biopsy associated with fewer acute rejections following combined liver-kidney transplantation: possible implications for monitoring patients. Hum Immunol 64 (2003) 1033-1038
29. Qiu J., Terasaki P.I., Miller J., et al. Soluble HLA-G expression and renal graft acceptance. Am J Transplant 6 (2006) 2152-2156
30. Xydas S., Yang J.K., Burke E.M., et al. Utility of post-transplant anti-HLA antibody measurements in pediatric cardiac transplant recipients. J Heart Lung Transplant 24 (2005) 1289-1296